Taylor I. Liu
Kaiser Permanente
9 Papers
35 Citations
Taylor I. Liu is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Hazard ratio & Atrial fibrillation. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study.
Alan S. Go,Alan S. Go,Alan S. Go,Kristi Reynolds,Jingrong Yang,Nigel Gupta,Judith C Lenane,Sue Hee Sung,Teresa N. Harrison,Taylor I. Liu,Matthew D. Solomon,Matthew D. Solomon +11 more
TL;DR: A greater burden of atrial fibrillation is associated with a higher risk of ischemic stroke independent of known stroke risk factors in adults with paroxysmal atrial Fibrillation.
Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia
Alan S. Go,Alan S. Go,Alan S. Go,Mark A. Hlatky,Mark A. Hlatky,Taylor I. Liu,Dongjie Fan,Elisha Garcia,Sue Hee Sung,Matthew D. Solomon,Matthew D. Solomon +10 more
TL;DR: It is projected that at least 0.168% of US adults experience symptomatic PSVT, and certain characteristics can identify people at higher risk.
30
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network
Frederick A. Masoudi,Frederick A. Masoudi,Alan S. Go,Alan S. Go,David J. Magid,David J. Magid,Andrea E. Cassidy-Bushrow,Jerry H. Gurwitz,Taylor I. Liu,Kristi Reynolds,David H. Smith,Liza M. Reifler,Karen A. Glenn,Frances Fiocchi,Robert J. Goldberg,Nigel Gupta,Pamela N. Peterson,Pamela N. Peterson,Pamela N. Peterson,Claudio Schuger,Humberto Vidaillet,Stephen C. Hammill,Robert T. Greenlee +22 more
TL;DR: The burden of adverse outcomes after receipt of an implantable cardioverter-defibrillator for primary prevention is substantial and varies according to patient age and sex, but differences in outcome generally do not vary according to baseline heart failure characteristics.
Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications.
James V. Freeman,Grace H. Tabada,Kristi Reynolds,Sue Hee Sung,Daniel E. Singer,Paul J. Wang,Taylor I. Liu,Nigel Gupta,Mark A. Hlatky,Alan S. Go +9 more
TL;DR: In a contemporary, multicenter, propensity-matched observational cohort, AF ablation was not significantly associated with death, intracranial hemorrhage, ischemic stroke or transient isChemic attack, or heart failure hospitalization, but was associated with a higher rate of all cause-hospitalization.
8
Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies.
Alexandra M. Hajduk,Jerry H. Gurwitz,Grace H. Tabada,Frederick A. Masoudi,David J. Magid,David J. Magid,Robert T. Greenlee,Sue Hee Sung,Andrea E. Cassidy-Bushrow,Taylor I. Liu,Kristi Reynolds,David H. Smith,Frances Fiocchi,Robert J. Goldberg,Thomas M. Gill,Nigel Gupta,Pamela N. Peterson,Pamela N. Peterson,Claudio Schuger,Humberto Vidaillet,Stephen C. Hammill,Heather G. Allore,Alan S. Go,Alan S. Go,Alan S. Go +24 more
TL;DR: To determine whether burden of multiple chronic conditions (MCCs) influences the risk of receiving inappropriate vs appropriate device therapies, a large number of patients with MCCs were randomly assigned to receive either inappropriate or appropriate therapies.